An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat ...
Feb 18, 2015
0
19
Duke Medicine researchers have shown how gene mutations may cause common forms of cartilage tumors.
Feb 16, 2015
0
62
Failure to accept illness is associated with poorer quality of life in patients with chronic heart failure, according to research published today in the European Journal of Cardiovascular Nursing. Patients with lower illness ...
Jan 7, 2015
0
13
When metastatic cancer spreads to the spine, it can cause spinal fractures, severe pain and impaired mobility.
Jan 5, 2015
0
7
(HealthDay)—Exercise helps relieve aromatase inhibitor (AI)-induced pain in breast cancer survivors, according to research published online Dec. 1 in the Journal of Clinical Oncology.
Dec 10, 2014
0
0
Children in emergency departments can safely be treated for pain from limb injuries using intranasal ketamine, a drug more typically used for sedation, according to the results of the first randomized, controlled trial comparing ...
Dec 4, 2014
0
0
Austrian surgeons removed a tumour weighing some eight kilos (18 pounds), as heavy as a seven-month-old baby, from the stomach of a 75-year-old woman, doctors said Thursday.
Sep 4, 2014
0
0
(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...
Jul 25, 2014
0
0
(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...
Jul 25, 2014
0
0
(Medical Xpress)—Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers.
Jun 30, 2014
0
3
